Caxton Associates (UK)’s IMAX IMAX Stock Holding History

Caxton Associates (UK)’s Portfolio IMAX Stock Details IMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,153	Closed	-$228K	–	828
2025 Q2	$228K	Buy	+8,153	New	+$212K	0.01%	603

Other funds holding IMAX

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caxton Associates (UK)'s IMAX Position: Q3 2025 in Review

Caxton Associates (UK) sold out of IMAX (IMAX) in Q3 2025, closing a stake of 8,153 shares — an estimated $228K sold.

Caxton Associates (UK) first reported a position in IMAX in Q2 2025 and held it in 1 quarter. The position peaked at $228K in Q2 2025. 209 funds tracked by Wall St. Rank hold IMAX as of Q3 2025.

Caxton Associates (UK) reported no remaining IMAX position as of Q3 2025 after selling out during the quarter.
Caxton Associates (UK) sold 8,153 IMAX shares in Q3 2025, an estimated $228K.
Caxton Associates (UK) first reported a position in IMAX in Q2 2025 and held it in 1 quarter.
Caxton Associates (UK)'s IMAX position peaked at $228K in Q2 2025.
209 funds tracked by Wall St. Rank held IMAX as of Q3 2025.

Based on Caxton Associates (UK)'s 13F filing for Q3 2025, filed 17 Nov 2025.